Radionetics

formerly Radionetics Oncology

The power to stop cancer.

San Diego, United States · Founded 2021 · $222.5M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$222.5M
Last Round
$140.0M Corporate RoundJul 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Radionetics Oncology is a clinical-stage precision oncology company focused on discovering and developing novel small molecule radiopharmaceuticals that target G protein-coupled receptors (GPCRs) overexpressed on cancer cells. Spun out of Crinetics Pharmaceuticals in October 2021 with $30 million in initial funding, Radionetics applies deep GPCR biology expertise and medicinal chemistry to build a modular radiopharmaceutical platform capable of addressing a broad range of solid tumors including breast and lung cancer. In July 2024, Radionetics entered a strategic agreement with Eli Lilly — receiving $140 million upfront — granting Lilly the exclusive right to acquire Radionetics for up to $1 billion. The company is headquartered in San Diego, California.

Summary

Radionetics is a Biotech company based in San Diego, United States, founded in 2021. It has raised $222.5M in total across 3 rounds, most recently a $140.0M Corporate Round in Jul 2024. Investors include Frazier Life Sciences, 5AM Ventures and Eli Lilly.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundJul 2024
$140.0M

Sign up to see all 3 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare
Private EquityTotal funding$3.3BApr 2022
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Radionetics on Indexed.vc
<a href="https://indexed.vc/companies/radionetics"><img src="https://indexed.vc/api/badge/company/radionetics" alt="Radionetics on Indexed.vc" width="260" height="76" /></a>